Table 3.
Triglyceride (natural log-transformed) and risk for CVD mortality among 26 570 adults
| Models | HR | 95% CI | P-value |
|---|---|---|---|
| Overall (n = 26 570) | |||
| ȃModel 1 | 1.24 | 1.12–1.36 | <0.001 |
| ȃModel 2 | 1.16 | 1.05–1.28 | 0.005 |
| ȃModel 3 | 1.12 | 1.01–1.24 | 0.033 |
| ȃModel 4 | 1.06 | 0.95–1.17 | 0.315 |
| Participants without diabetes (n = 22 592) | |||
| ȃModel 1 | 1.05 | 0.93–1.18 | 0.463 |
| ȃModel 2 | 0.97 | 0.86–1.10 | 0.641 |
| ȃModel 3 | 0.94 | 0.83–1.07 | 0.359 |
| ȃModel 4 | 0.95 | 0.83–1.07 | 0.382 |
| Participants with diabetes (n = 3978) | |||
| ȃModel 1 | 1.41 | 1.18–1.68 | <0.001 |
| ȃModel 2 | 1.31 | 1.09–1.57 | 0.004 |
| ȃModel 3 | 1.28 | 1.06–1.53 | 0.009 |
| ȃModel 4 | 1.30 | 1.08–1.56 | 0.006 |
CI, confidence interval; CVD, cardiovascular disease; HR, hazard ratio.
Model 1: adjusted for age, sex, and ethnicity. Model 2: adjusted for age, sex, ethnicity, obesity, poverty–income ratio, education, physical activity, alcohol consumption, smoking status, and survey period. Model 3: adjusted for all the factors in Model 2 plus hypercholesterolaemia and hypertension. Model 4: adjusted for all the factors in Model 3 plus diabetes, family history of diabetes, duration of diabetes, and diabetes medications.